Abstract
dc:descriptionOpioids are pluripotent agents, involved in a number of key actions, including antinociception, immunomodulation, inhibition of cancer cell growth and modulation of the motility of normal and cancer cells. The aim of the present study was to investigate opioid effects on two significant functions of the immune system: constitutive secretion and cell motility. Our results show that opioids decrease antibody and cytokine secretion by both multiple myeloma cell lines (LP-1 and RPMI8226) and normal B lymphocytes (CD19+) and inhibit their growth. On the contrary, secretion of IgE and IL-6 by U266 cells was increased, while their proliferation was also inhibited. Our data present for the first time two different mechanisms of opioid action on B-cells: an early, non-opioid receptorrelated mechanism, controlling antibody and cytokine secretion, and a receptormediated long-term action on cell growth. The first mechanism, involves JNK/c-Jun and/or p38/CREB to modulate secretion, while the second mechanism, involving opioid receptors, is mediated through PI3k/Akt inhibition to suppress cell proliferation. Both mechanisms relay the opioid system (circulating or locally produced opioids) in humoral immunity regulation. These data provide some additional information concerning opioid effects on B-cells, which until recently, are reported to be indirect, through the modulation of humoral agents secreted by other immune cells and interplay of distinct cell populations (e.g T-cells, macrophages). Further identification and characterization of signal transduction pathways responsible for these unique properties of opioids may represent major research challenge ahead. The study of lymphocyte migration in vitro is rather complicated, due to the need of cocultures of different cell systems. Therefore, we examined the effects of opioids on migration of cancer cells instead, since most structural and regulatory molecules used in the migratory process seem to be similar among migrating cells. Furthermore, the investigation of opioid effects on cancer cell migration may provide further information on their metastatic properties, as cell migration is a prerequisite for cancer metastasis. In order to examine opioid actions on cell motility, we used cancer cells of different origin (bladder, liver, cervix, ovary and breast). Our results showed that morphine has little effect on the metastatic properties (migration, adhesion and spreading on collagen type I) of hepatocyte (HepG2) and cervical (HeLa) cancer cells, while has not effect on breast (MCF-7) and ovarian cancer cells (SKOV-3). On the contrary, all opioids used, enhanced the metastatic properties of bladder cancer cells (T24 και EJ). Furthermore, 22 they induced invasiveness of these cells through ECM components, increased secretion of MMP-2 and -9 and induced rearrangements of filamentous actin cytoskeleton. These actions were mediated by p38, ERK 1/2, PI3k and -to a lesser degree- JNK activation through a non-opioid receptor related manner. Moreover, a novel interaction of opioids with bradykinin B2 receptor was characterized, mediating opioid effects on bladder cancer cell migration, suggesting a new role of opioids in the cancer process. ...
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vassou, Despoina
- Βάσσου, Δέσποινα
Subjects
dc:subject × 20- Οπιοειδή
- Β λεμφοκύτταρα
- Πολλαπλό μυέλωμα
- Ανοσοσφαιρίνες
- Έκκριση
- Μετανάστευση
- Υποδοχέας Β2 βραδυκινίνης
- Καρκίνος ουροδόχου κύστης
- Opioids
- B lympholytes
- Multiple myeloma
- Antibodies
- Secretion
- Migration
- Bradykinin b2 receptor
- Bladder cancer
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24582